US Broker Ratings

Incyte Corporation (INCY): Investor Outlook Reveals a 13.38% Potential Upside Amidst Robust Revenue Growth

Incyte Corporation (NASDAQ: INCY) stands out in the biotechnology sector as a formidable player, given its strategic focus on developing and commercializing innovative therapies. With a market capitalization of $19.09..

The Cooper Companies, Inc. (COO) Investor Outlook: Potential Upside of Nearly 19% Amid Strong Buy Ratings

For investors seeking opportunities in the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents a compelling case. As a leader in the medical instruments and supplies industry, COO is..

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring a Promising 11.27% Potential Upside

Oscar Health, Inc. (NYSE: OSCR) has been making waves in the healthcare sector with its innovative approach to health insurance and technology. As a healthcare technology company, Oscar Health operates..

Viatris Inc. (VTRS) Investor Outlook: Evaluating a Stock with a 9.46% Potential Upside

Viatris Inc. (VTRS) presents an intriguing opportunity for investors looking to diversify within the healthcare sector, particularly in the realm of specialty and generic drug manufacturing. With a substantial market..

Masimo Corporation (MASI) Stock Analysis: Evaluating Growth Potential Amid Healthcare Innovation

Masimo Corporation (MASI), a prominent player in the healthcare sector, is making waves in the medical devices industry with its cutting-edge patient monitoring technologies. Headquartered in Irvine, California, Masimo is..

RadNet, Inc. (RDNT) Stock Analysis: Potential 52% Upside in Healthcare Diagnostics

RadNet, Inc. (RDNT), a prominent player in the healthcare sector specializing in diagnostics and research, has been capturing the attention of investors with its robust growth potential and innovative offerings..

Legend Biotech Corporation (LEGN) Stock Analysis: Unpacking a 209% Potential Upside in Biotech

Legend Biotech Corporation (NASDAQ: LEGN) is creating a buzz among investors with its remarkable potential upside, estimated at 209.42%. This biopharmaceutical company, headquartered in Somerset, New Jersey, is making waves..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unlocking a 23.31% Potential Upside in the Diagnostics Sector

Investors seeking opportunities in the healthcare sector, particularly in the diagnostics and research industry, should consider IDEXX Laboratories, Inc. (NASDAQ: IDXX). With a market capitalization of $48.58 billion, this American..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 21.55% Potential Upside in the Healthcare Sector

TransMedics Group, Inc. (NASDAQ: TMDX) is a pioneering player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $4.45 billion, TransMedics is making significant..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A Lucrative 6.74% Upside Amidst Robust Revenue Growth

Smith & Nephew SNATS, Inc. (NYSE: SNN), a leading player in the medical devices sector, presents an intriguing opportunity for investors seeking exposure to the healthcare industry. With a market..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 22.47% Potential Upside in the Medical Devices Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) presents an intriguing opportunity for investors within the healthcare sector, specifically in the field of medical devices. With a market capitalization of $1.83 billion,..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 9.59% Upside with Solid Dividend Yields

Takeda Pharmaceutical Company Limited (NYSE: TAK), a venerable giant in the healthcare sector, stands out with its impressive $56.49 billion market capitalization. Headquartered in Tokyo, Japan, Takeda has built a..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A 50.91% Upside Potential Awaits Investors

Cytokinetics, Incorporated (NASDAQ: CYTK), a biopharmaceutical innovator in the biotechnology industry, is making waves with its cutting-edge treatments targeting muscle function. With a market cap of $7.39 billion, the company..

Atrium Therapeutics (RNA) Stock Report: Navigating the Biotech Sector with a Market Cap of $229.93 Million

Atrium Therapeutics, Inc. (RNA) is carving its niche in the dynamic biotechnology sector, with a particular focus on RNA therapeutics aimed at treating cardiomyopathies. Headquartered in San Diego, California, this..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 39.64% Potential Upside in Healthcare Innovation

Bio-Techne Corp (NASDAQ: TECH) is a prominent player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $8.43 billion and a robust portfolio of life..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Capitalizing on a 49.91% Potential Upside with Groundbreaking Biopharma Innovations

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a commercial-stage biopharmaceutical firm, is capturing significant attention in the biotechnology sector due to its pioneering focus on rare neuroendocrine diseases. Headquartered in Boston, Massachusetts,..

Glaukos Corporation (GKOS) Stock Analysis: Understanding the 25% Potential Upside

Glaukos Corporation (NYSE: GKOS), a leader in the medical devices sector with a focus on ophthalmic pharmaceuticals and medical technology, has been making waves in the healthcare industry. With a..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring an 83.84% Potential Upside in Biotech Innovation

Vaxcyte, Inc. (NASDAQ: PCVX) is capturing investor attention with its remarkable potential upside of 83.84%, as evidenced by the average analyst target price of $109, compared to its current trading..

Haleon plc (HLN) Stock Analysis: Navigating a 16.03% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a pivotal player in the healthcare sector, presents a compelling investment opportunity with a notable potential upside of 16.03%, according to the latest analyst ratings. Operating from..

Quest Diagnostics (DGX) Stock Analysis: Unlocking a 9.68% Potential Upside in Healthcare Diagnostics

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth prospects. With a market cap..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds